13F Holdings
中文EN

PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1299130 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.0%
TTM net income YoY75.0%
TTM EPS YoY81.2%
Revenue 3-yr CAGR2.9%
Net income 3-yr CAGR—

Margins

Gross margin36.4%
Operating margin-83.5%
Net margin-82.5%
FCF margin-77.5%
EBITDA margin-77.4%

Returns

ROE-929.3%
ROA-16.7%
ROIC (approx.)—
Asset turnover0.20x

Leverage & solvency

Liabilities / assets104.4%
Debt / equity—
Current ratio4.92x
Interest coverage-18.15x

Cash quality & payout

Operating cash flow / net income0.90x
Accruals ratio-1.7%
Payout ratio—
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$160.00M$154.01M$200.52M$128.30M$130.51M
Cost of revenue$114.22M$116.73M$147.74M$79.27M$71.65M
Gross profit$45.78M$37.28M$52.78M$49.03M$58.86M
R&D expense$97.31M$134.92M$187.17M$193.00M$112.90M
SG&A expense$141.49M$175.02M$169.82M$160.85M$124.12M
Operating income-$553.86M-$474.31M-$334.47M-$307.20M-$210.44M
Interest expense$6.95M$13.41M$14.34M$14.69M$12.53M
Pretax income-$546.06M-$309.54M-$318.16M-$314.25M-$274.87M
Income tax$318,000$316,000-$11.42M$0-$93.65M
Net income-$546.38M-$309.85M-$306.74M-$314.25M-$181.22M
EBITDA-$540.87M-$460.54M-$323.00M-$297.72M-$203.24M
EPS (basic)-1.82-1.13-1.21-1.40-0.89
EPS (diluted)-1.82-1.59-1.21-1.40-0.89
Dividends declared per share0.000.000.000.000.00
Weighted avg. shares (diluted)299.96M288.37M253.63M224.55M204.14M
Balance sheet
Cash & equivalents$63.71M$57.59M$179.91M$328.31M$465.82M
Short-term investments$215.80M$334.56M$451.50M$447.23M$583.67M
Receivables$35.45M$27.52M$36.62M$18.79M$24.24M
Inventory$49.28M$58.76M$56.68M$50.38M$24.60M
Current assets$375.05M$495.68M$742.05M$852.07M$1.10B
PP&E, net$24.15M$30.50M$36.43M$41.58M$32.50M
Goodwill$317.76M$317.76M$462.26M$409.97M$409.97M
Intangibles$15.12M$389.57M$456.98M$410.25M$410.98M
Total assets$784.08M$1.26B$1.75B$1.77B$2.01B
Current liabilities$72.83M$66.30M$95.03M$263.33M$71.71M
Short-term debt—$0$490,000$1.84M$1.61M
Long-term debt———$896.68M$896.07M
Total debt———$898.52M$897.67M
Total liabilities$778.73M$753.85M$1.04B$1.20B$1.22B
Shareholders' equity$5.35M$506.59M$701.30M$562.90M$790.99M
Net debt———$570.21M$431.86M
Shares outstanding301.96M294.42M267.74M226.50M220.98M
Cash flow statement
Operating cash flow-$111.21M-$206.06M-$259.17M-$263.21M-$111.18M
Capital expenditure$2.71M$6.19M$8.84M$16.75M$5.93M
Free cash flow-$113.92M-$212.25M-$268.02M-$279.96M-$117.11M
Investing cash flow$115.45M$124.00M$4.60M$116.08M-$678.53M
Financing cash flow$3.43M-$42.99M$108.89M$9.62M$1.17B
Depreciation & amortization$12.99M$13.77M$11.46M$9.48M$7.20M
Stock-based compensation$41.67M$71.04M$72.12M$78.61M$73.36M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.